References
- 1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 Feb;4(2):295-306. DOI: 10.1111/j.1538-7836.2006.01753.x10.1111/j.1538-7836.2006.01753.x
- 2. Nayfe R, Uthman I, Aoun J, Saad Aldin E, Merashli M, Khamashta MA. Seronegative antiphospholipid syndrome. Rheumatology (Oxford). 2013 Aug;52(8):1358-67. DOI: 10.1093/rheumatology/ket126
- 3. Staub HL, Bertolaccini ML, Khamashta MA. Anti- phosphatidylethanolamine antibody, thromboembolic events and the antiphospholipid syndrome. Autoimmun Rev. 2012 Dec;12(2):230-4. DOI: 10.1016/j.autrev.2012.07.00810.1016/j.autrev.2012.07.008
- 4. Bertolaccini ML, Amengual O, Andreoli L, Atsumi T, Chighizola CB, Forastiero R, et al. 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmun Rev. 2014 Sep;13(9):917-30. DOI: 10.1016/j.autrev.2014.05.00110.1016/j.autrev.2014.05.001
- 5. Sestak A, O’Neil KM. Familial lupus and antiphospholipid syndrome. Lupus. 2007; 16(8): 556-63. DOI: 10.1177/0961203307078071
- 6. Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, et al. Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis. 2005 Nov;64(11):1639-43. DOI: 10.1136/ard.2005.03582410.1136/ard.2005.035824
- 7. Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, et al. Identification of rare anti-phospholipid/ protein co-factor autoantibodies in patients with systemic lupus erythematosus. Autoimmunity. 2009 Sep;42(6):497-506. DOI: 10.1080/0891693090288273110.1080/08916930902882731
- 8. Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012 Aug;64(8):2677-86. DOI: 10.1002/art.34473
- 9. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 Jun;35(6):630-40. DOI: 10.1002/art.178035060610.1002/art.1780350606
- 10. Gavris C, Anghel M, Radoi M, Gheorghita E, Duca L, Pamfil G, et al. Risk of recurrent thrombosis related to antiphospholipid antibodies, soluble CD40L and P selectin serum levels in patients with antiphospholipid syndrome secondary to systemic lupus eritematosus. RRML. 2010 Sept;3(4):23-28.
- 11. Wahl DG, Guillemin F, de Maistre E, Perret C, Lecompte T, Thibaut G. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus-a meta-analysis. Lupus. 1997;6(5):467-73. DOI: 10.1177/09612033970060051010.1177/096120339700600510
- 12. Somers E, Magder LS, Petri M. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol. 2002 Dec;29(12):2531-6.
- 13. Petri M. Update on anti-phospholipid antibodies in SLE: the Hopkins’ Lupus Cohort. Lupus. 2010 Apr;19(4):419-23. DOI: 10.1177/096120330936054110.1177/0961203309360541
- 14. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003 Mar;101(5):1827-32. DOI: 10.1182/blood-2002-02-044110.1182/blood-2002-02-0441
- 15. Bertolaccini ML. Antibodies to prothrombin. Lupus. 2012 Jun;21(7):729-31. DOI: 10.1177/096120331244329910.1177/0961203312443299
- 16. Bertolaccini ML, Murru V, Sciascia S, Sanna G, Khamashta MA. The clinical value of testing for antibodies to phosphatidylethanolamine (aPE) in patients with systemic lupus erythematosus (SLE). Thromb Res. 2012 Dec;130(6):914-8. DOI: 10.1016/j.thromres.2012.06.008
- 17. Sanmarco M, Gayet S, Alessi MC, Audrain M, de Maistre E, Gris JC, et al. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies. Thromb Haemost. 2007 Jun;97(6):949-54. DOI: 10.1160/TH06-10-060410.1160/TH06-10-0604
- 18. Sanmarco M, Bardin N. The contribution of antiphosphatidylethanolamine antibodies in the diagnosis of the antiphospholipid syndrome. Lupus. 2012 Jun;21(7):727-8. DOI: 10.1177/096120331243727210.1177/0961203312437272
- 19. Matta BN, Uthman I, Taher AT, Khamashta MA. The current standing of diagnosis of antiphospholipid syndrome associated with systemic lupus erythematosus. Expert Rev Clin Immunol. 2013 Jul;9(7):659-68. DOI: 10.1586/1744666X.2013.81118310.1586/1744666X.2013.811183